Controversial issues in the management of hyperprolactinemia and prolactinomas–An overview by the Neuroendocrinology Department of the Brazilian Society of …

L Vilar, J Abucham, JL Albuquerque… - … of endocrinology and …, 2018 - SciELO Brasil
Prolactinomas are the most common pituitary adenomas (approximately 40% of cases), and
they represent an important cause of hypogonadism and infertility in both sexes. The …

Gamma knife radiosurgery for pituitary tumors: a systematic review and meta-analysis

L Albano, M Losa, LR Barzaghi, A Niranjan, Z Siddiqui… - Cancers, 2021 - mdpi.com
Simple Summary Pituitary tumors represent approximately 10–15% of all brain neoplasms.
Gamma Knife, the most commonly used stereotactic radiosurgery technique worldwide …

[PDF][PDF] Position statement for clinical practice: prolactin-secreting tumors

R Cozzi, MR Ambrosio, R Attanasio… - European Journal of …, 2022 - research.unipd.it
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin …

R Cozzi, MR Ambrosio, R Attanasio… - European journal of …, 2022 - academic.oup.com
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

[HTML][HTML] Functioning pituitary adenomas–current treatment options and emerging medical therapies

EV Varlamov, S McCartney, M Fleseriu - European Endocrinology, 2019 - ncbi.nlm.nih.gov
Pituitary adenomas are benign tumours comprising approximately 16% of all primary cranial
neoplasms. Functioning pituitary adenomas (prolactinomas, somatotroph, corticotroph …

Target delineation and optimal radiosurgical dose for pituitary tumors

G Minniti, MF Osti, M Niyazi - Radiation oncology, 2016 - Springer
Stereotactic radiosurgery (SRS) delivered as either single-fraction or multi-fraction SRS (2–5
fractions) is frequently employed in patients with residual or recurrent pituitary adenoma …

Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?

DA Niculescu, ML Gheorghiu… - European Journal of …, 2023 - academic.oup.com
Radiotherapy, conventional or radiosurgery, has been used to control prolactin secretion
and tumour growth in prolactinomas both as part of multimodal therapy or rarely as primary …

[HTML][HTML] Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations

D Mathieu, R Kotecha, A Sahgal, A De Salles… - Journal of …, 2021 - thejns.org
OBJECTIVE A systematic review was performed to provide objective evidence on the use of
stereotactic radiosurgery (SRS) in the management of secretory pituitary adenomas and …

Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis

A Hoffmann, S Adelmann, K Lohle, A Claviez… - European journal of …, 2018 - Springer
Prolactinoma is a rare pituitary adenoma secreting prolactin. Studies on diagnostics,
treatment, and prognosis in pediatric prolactinoma patients are rare. We analyzed clinical …

Magnetic resonance imaging in the management of prolactinomas; a review of the evidence

EV Varlamov, JM Hinojosa-Amaya, M Fleseriu - Pituitary, 2020 - Springer
Purpose This review aimed to evaluate data on the use of magnetic resonance imaging in
the management of prolactinomas. Methods Recent literature about prolactinoma behavior …